Our results indicate that beyond targeting the deacetylase activity of SIRT2, developing novel methods to enhance the association of SIRT2 with OGG1 might be a promising approach for cancer prevention and the treatment of neurodegenerative diseases that are associated with the rise in genomic instability resulting from oxidative stress (76). This evidence concerns the gene OGG1 and cancer.